Spectrum Vascular

Spectrum Vascular is a medical device manufacturer founded in 2023, specializing in vascular access and medication management solutions with a focus on reducing catheter-related complications. The company develops a range of central venous catheters (CVCs), peripherally inserted central catheters (PICCs), midline catheters, and arterial lines incorporating proprietary antimicrobial and thromboresistant technologies. SV Spectrum™ Technology features antimicrobial catheters designed to prevent central line-associated bloodstream infections (CLABSI) and catheter-related bloodstream infections (CRBSI), validated by over 30 peer-reviewed studies. SV BioFlo Technology incorporates Endexo® surface-modifying macromolecules to minimize thrombus accumulation and catheter occlusions throughout the catheter's lifespan. Additional offerings include intraosseous (IO) needles, ECG-guided catheter placement systems, and accessory products. Spectrum Vascular's mission addresses the significant clinical and economic burden of vascular access infections and complications, with typical CRBSI treatment costs exceeding $45,000 per case.